| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |